The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury
about
Hematopoietic stem cell development, niches, and signaling pathwaysUsing mesenchymal stem cells as a therapy for bone regeneration and repairingDipeptidyl Peptidase-4 Regulation of SDF-1/CXCR4 Axis: Implications for Cardiovascular DiseaseStrategies to improve the immunosuppressive properties of human mesenchymal stem cellsRegenerative medicine for the kidney: renotropic factors, renal stem/progenitor cells, and stem cell therapyThe Regenerative Role of the Fetal and Adult Stem Cell SecretomeOptimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cellsAdult Stem Cell Therapy for Stroke: Challenges and ProgressMultimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing.The regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells.From isolation to implantation: a concise review of mesenchymal stem cell therapy in bone fracture repair.Hypoxic Preconditioning Promotes the Bioactivities of Mesenchymal Stem Cells via the HIF-1α-GRP78-Akt Axis.Mesenchymal stem cell treatment for chronic renal failure.The effects of ABCG2 on the viability, proliferation and paracrine actions of kidney side population cells under oxygen-glucose deprivation.Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regenerationMesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.Isolation and characterization of two kinds of stem cells from the same human skin back sample with therapeutic potential in spinal cord injury.CXCR7 silencing attenuates cell adaptive response to stromal cell derived factor 1α after hypoxia.Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury.Protective effects of mesenchymal stem cells with CXCR4 up-regulation in a rat renal transplantation model.Hypoxia precondition promotes adipose-derived mesenchymal stem cells based repair of diabetic erectile dysfunction via augmenting angiogenesis and neuroprotectionStromal cell-derived factor-1 (SDF1)-dependent recruitment of bone marrow-derived renal endothelium-like cells in a mouse model of acute kidney injuryHypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro.Extracellular vesicles derived from renal cancer stem cells induce a pro-tumorigenic phenotype in mesenchymal stromal cells.Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosisSDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease.Nephroprotective Effects of Polydatin against Ischemia/Reperfusion Injury: A Role for the PI3K/Akt Signal Pathway.Mesenchymal stem cells attenuate acute ischemia-reperfusion injury in a rat model.Heat shock pretreatment improves stem cell repair following ischemia-reperfusion injury via autophagy.HIF-1α Overexpression Induces Angiogenesis in Mesenchymal Stem Cells.Hypoxic preconditioning increases the protective effect of bone marrow mesenchymal stem cells on spinal cord ischemia/reperfusion injury.Mesenchymal stromal cells in transplantation rejection and tolerance.Preconditioning diabetic mesenchymal stem cells with myogenic medium increases their ability to repair diabetic heart.Reconstitution of kidney side population cells after ischemia-reperfusion injury by self-proliferation and bone marrow-derived cell homing.Stromal cell-derived factor-1 promotes human adipose tissue-derived stem cell survival and chronic wound healingPossible Mechanism of Therapeutic Effect of 3-Methyl-1-phenyl-2-pyrazolin-5-one and Bone Marrow Stromal Cells Combination Treatment in Rat Ischemic Stroke Model.Mesenchymal stem cells in tissue repairPriming adult stem cells by hypoxic pretreatments for applications in regenerative medicine.Effect of low oxygen tension on the biological characteristics of human bone marrow mesenchymal stem cells.Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning.
P2860
Q21296679-D84822BE-8CD6-4A6A-B294-804AD7E4E701Q26777025-7B0FAF0D-A494-4457-92A1-548A7A522297Q26781269-0E97609F-7980-470B-8E07-F18C8DC8CA50Q26786626-24B5FB03-DC4A-454F-B25F-96108CCBF63AQ26865171-4029A586-87E3-4FA5-9596-3BA11B24BFD0Q27004398-71ED5372-4E7B-45F8-8518-F3E98DFE30C5Q27015774-DAF872F0-7871-4709-ABAE-12ADE55B64EBQ28066235-9B0C88CC-DEBC-482E-8FFB-43CD22BDC14EQ30530998-C4865791-4C2B-48EB-A447-CFD293E477CEQ33563134-0A19AC89-A8D3-43B2-B952-D8C4B84EAB16Q33746706-7CAE57DC-1CB1-461E-93F8-559DE713EE2FQ33839162-83645926-847D-4E29-91C1-0B841D3B5EB4Q33900483-72934AF4-F43B-4837-B260-DFF5DAEFF152Q33970372-6536B4B9-DD5F-4428-B5A0-DCBA9F7FE756Q34405145-D8DD5507-91FB-4DE5-9B10-3B5864EDA4AEQ34487787-26022655-96FA-4F11-83F5-7C9063977E82Q34505175-6C138C33-612C-4238-A25E-8D12F5BB30C8Q34576325-F9797547-1321-4375-9A49-F977A86B4151Q34720770-E7F6F3D9-4C45-432F-9A36-DCD7F988003BQ35080099-F8928AC7-BB5F-4D9E-8180-AB28B57227F7Q35196216-2871DCF2-8BD8-4D80-BDC1-13D7614DE9F2Q35252477-62E859E1-9DDF-4C83-AA4A-CB098718ACB5Q35779127-DB499C53-A772-4E49-9531-8E82C6520249Q35781475-41DA5F5F-92D6-40D2-8784-171278504ED9Q35805322-FBCB53DF-4478-4DE2-82FE-55C645FBF9C5Q36126656-A8D3985F-35D3-43D9-B591-4CC3041F3880Q36241529-C309D520-2B57-449D-9C95-656C9D637A73Q36334068-D8B4854F-C4AC-4761-ADDF-3EAD23E271C4Q36350224-AF30CCD4-6DE5-45F6-96EF-41805091217BQ36574446-811EA205-945A-4F34-B7DF-E33E40E78449Q36623969-B8FCCCB0-A8AF-407F-BB81-FEE5B15DFF32Q36786630-812EEDFE-0A82-4555-ADCC-8CA3F94B07A5Q36998592-9EC3C734-5441-4135-9C0C-C743C48D39FBQ36999480-D036817B-68C8-4C77-AFEC-AE3BB77F92C6Q37001762-41979E42-1355-447C-B6B6-6968FF448AACQ37011365-5F195C72-2D2D-4837-BFD4-D16779ED2FB0Q37142817-81F8EACE-42E2-49B8-AC53-E940068865B0Q37153287-19DE4FD2-F039-47FE-8A42-03DB679E653EQ37372975-40EB8D8C-13DD-4978-B151-9D0408D90580Q37394751-0A8F564C-BE15-42F8-8D8A-1CEC146B3E15
P2860
The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The role of SDF-1-CXCR4/CXCR7 ...... al ischemia/reperfusion injury
@ast
The role of SDF-1-CXCR4/CXCR7 ...... al ischemia/reperfusion injury
@en
The role of SDF-1-CXCR4/CXCR7 ...... al ischemia/reperfusion injury
@nl
type
label
The role of SDF-1-CXCR4/CXCR7 ...... al ischemia/reperfusion injury
@ast
The role of SDF-1-CXCR4/CXCR7 ...... al ischemia/reperfusion injury
@en
The role of SDF-1-CXCR4/CXCR7 ...... al ischemia/reperfusion injury
@nl
prefLabel
The role of SDF-1-CXCR4/CXCR7 ...... al ischemia/reperfusion injury
@ast
The role of SDF-1-CXCR4/CXCR7 ...... al ischemia/reperfusion injury
@en
The role of SDF-1-CXCR4/CXCR7 ...... al ischemia/reperfusion injury
@nl
P2093
P2860
P1433
P1476
The role of SDF-1-CXCR4/CXCR7 ...... al ischemia/reperfusion injury
@en
P2093
Guanqun Ge
Hongbao Liu
Shuibing Liu
Xiaohong Wang
Xiaohui Luo
P2860
P304
P356
10.1371/JOURNAL.PONE.0034608
P407
P577
2012-04-12T00:00:00Z